Skip to main content
Signal8

Bowen Matthew

SEC insider (Form 3/4/5 filer). CIK 0002115025. Principal Accounting Officer at Monte Rosa Therapeutics, Inc. (GLUE). 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in BOSTON, MA.

Companies Bowen Matthew has filed insider reports for

  • Monte Rosa Therapeutics, Inc. (GLUE): Officer, Principal Accounting Officer
Bowen Matthew profile photo

Bowen Matthew

CIK: 0002115025

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Monte Rosa Therapeutics, Inc. logo
GLUE

Monte Rosa Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Monte Rosa Therapeutics, Inc. logo
    GLUE

    Monte Rosa Therapeutics, Inc.

    Oct 5, 2026
    Sale
    Direct
    13 shares at avg. $10.56$137.28
  • Monte Rosa Therapeutics, Inc. logo
    GLUE

    Monte Rosa Therapeutics, Inc.

    Apr 6, 2026
    Award
    Direct
    4.3K shares-

1-2 of 2